Welcome to our dedicated page for INNOSPEC SEC filings (Ticker: IOSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innospec Inc. filings document the financial reporting, governance and capital-return disclosures of a specialty chemicals operating company. Form 8-K reports record quarterly and annual results, segment commentary for Performance Chemicals, Fuel Specialties and Oilfield Services, Regulation FD disclosures, semi-annual dividends and board-authorized common stock repurchase programs.
The company’s proxy materials describe annual meeting matters, director elections, executive compensation votes, auditor ratification and related governance procedures. Its filings also identify IOSP common stock as a NASDAQ-listed security and provide formal disclosure around results of operations, financial condition, risk-related business context and shareholder voting matters.
Innospec Inc. reported that it issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. The company also declared a semi-annual dividend of $0.87 per share on its common stock.
The dividend will be paid on November 26, 2025 to shareholders of record as of November 18, 2025. The press release was furnished as Exhibit 99.1, providing details on the quarter’s performance.
Innospec’s Q2 2025 10-Q shows mixed performance. Net sales rose 1% YoY to $439.7 m, but net income fell 25% to $23.5 m (EPS $0.94). Lower profitability stemmed from a 120 bp drop in aggregate gross margin to 28.0% and a 3% rise in operating expenses; operating income declined 16% to $34.3 m.
Segment results were uneven: Fuel Specialties boosted gross margin 350 bp to 38.1% and operating income 16% to $35.4 m, while Performance Chemicals margin contracted 510 bp and Oilfield Services revenue fell 7%. For the first half, sales slipped 6% to $880.5 m and net income dropped 22% to $56.3 m (diluted EPS $2.24).
Cash from operations shrank to $37.6 m (-56% YoY) as inventories climbed $35.8 m. Nevertheless, cash & equivalents remain solid at $266.6 m; the $250 m revolver is undrawn and the company carries no long-term debt. Equity improved to $1.30 bn on retained earnings and a $57.6 m favorable FX translation adjustment.
Capital deployment included $32.2 m of capex/ERP spend, $20.8 m dividends ($0.84 / share) and $13.3 m share buybacks under a new $50 m program. Plant-closure provisions were raised $4.1 m and FX hedges produced a $6.4 m loss. Management cites softer demand in Oilfield Services and price pressure in Performance Chemicals, but highlights margin gains in Fuel Specialties and low leverage.